Suchergebnisse - "Cubillo, Antonio"

PubPharm (7)

1

Dynamic Angiogenic Switch as Predictor of Response to Chemotherapy-Bevacizumab in Patients With Metastatic Colorectal Cancer

enthalten in: American journal of clinical oncology | 2019

von Cubillo, A. | Álvarez-Gallego, R. | Muñoz, M. | +13

2

Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer

enthalten in: International journal of cancer | 2018

von Van Cutsem, E. | Hidalgo, M. | Canon, J. | +11

3

A comparative study of neoadjuvant treatment with gemcitabine plus nab-paclitaxel versus surgery first for pancreatic adenocarcinoma

enthalten in: Surgical oncology | 2017

von Ielpo, B. | Caruso, R. | Duran, H. | +11

4

Quality-adjusted survival with combination nal-IRI+5-FU/LV vs 5-FU/LV alone in metastatic pancreatic cancer patients previously treated with gemcitabine-based therapy : a Q-TWiST analysis

enthalten in: British journal of cancer | 2017

von Pelzer, U. | Blanc, J. | Melisi, D. | +11

5

Phase I clinical and pharmacokinetic study of PM01183 (a tetrahydroisoquinoline, Lurbinectedin) in combination with gemcitabine in patients with advanced solid tumors

enthalten in: Investigational new drugs | 2017

von Paz-Ares, L. | Forster, M. | Boni, V. | +9

6

Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1) : a global, randomised, open-label, phase 3 trial

enthalten in: Lancet (London, England) | 2016

von Wang-Gillam, A. | Li, C. | Bodoky, G. | +79

CommentIn: Lancet. 2016 Feb 6;387(10018):507-8. - PMID 26616909

7

A prospective pilot study of target-guided personalized chemotherapy with intensity-modulated radiotherapy in patients with early rectal cancer

enthalten in: American journal of clinical oncology | 2014

von Cubillo, A. | Hernando-Requejo, O. | García-García, E. | +10

1
[1]